» Articles » PMID: 11756561

Brca2 (XRCC11) Deficiency Results in Radioresistant DNA Synthesis and a Higher Frequency of Spontaneous Deletions

Abstract

We show here that the radiosensitive Chinese hamster cell mutant (V-C8) of group XRCC11 is defective in the breast cancer susceptibility gene Brca2. The very complex phenotype of V-C8 cells is complemented by a single human chromosome 13 providing the BRCA2 gene, as well as by the murine Brca2 gene. The Brca2 deficiency in V-C8 cells causes hypersensitivity to various DNA-damaging agents with an extreme sensitivity toward interstrand DNA cross-linking agents. Furthermore, V-C8 cells show radioresistant DNA synthesis after ionizing radiation, suggesting that Brca2 deficiency affects cell cycle checkpoint regulation. In addition, V-C8 cells display tremendous chromosomal instability and a high frequency of abnormal centrosomes. The mutation spectrum at the hprt locus showed that the majority of spontaneous mutations in V-C8 cells are deletions, in contrast to wild-type V79 cells. A mechanistic explanation for the genome instability phenotype of Brca2-deficient cells is provided by the observation that the nuclear localization of the central DNA repair protein in homologous recombination, Rad51, is reduced in V-C8 cells.

Citing Articles

ATR, CHK1 and WEE1 inhibitors cause homologous recombination repair deficiency to induce synthetic lethality with PARP inhibitors.

Smith H, Willmore E, Prendergast L, Curtin N Br J Cancer. 2024; 131(5):905-917.

PMID: 38965423 PMC: 11369084. DOI: 10.1038/s41416-024-02745-0.


Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells.

Martino J, Siri S, Calzetta N, Paviolo N, Garro C, Pansa M Elife. 2023; 12.

PMID: 37073955 PMC: 10185344. DOI: 10.7554/eLife.80254.


Counting the cost of public and philanthropic R&D funding: the case of olaparib.

Schmidt L, Sehic O, Wild C J Pharm Policy Pract. 2022; 15(1):47.

PMID: 35974344 PMC: 9379234. DOI: 10.1186/s40545-022-00445-9.


BRCA2 associates with MCM10 to suppress PRIMPOL-mediated repriming and single-stranded gap formation after DNA damage.

Kang Z, Fu P, Alcivar A, Fu H, Redon C, Foo T Nat Commun. 2021; 12(1):5966.

PMID: 34645815 PMC: 8514439. DOI: 10.1038/s41467-021-26227-6.


Strong functional data for pathogenicity or neutrality classify BRCA2 DNA-binding-domain variants of uncertain significance.

Richardson M, Hu C, Lee K, LaDuca H, Fulk K, Durda K Am J Hum Genet. 2021; 108(3):458-468.

PMID: 33609447 PMC: 8008494. DOI: 10.1016/j.ajhg.2021.02.005.


References
1.
Jones N, Stewart S, Thompson L . Biochemical and genetic analysis of the Chinese hamster mutants irs1 and irs2 and their comparison to cultured ataxia telangiectasia cells. Mutagenesis. 1990; 5(1):15-23. DOI: 10.1093/mutage/5.1.15. View

2.
Koi M, Shimizu M, Morita H, Yamada H, Oshimura M . Construction of mouse A9 clones containing a single human chromosome tagged with neomycin-resistance gene via microcell fusion. Jpn J Cancer Res. 1989; 80(5):413-8. PMC: 5917765. DOI: 10.1111/j.1349-7006.1989.tb02329.x. View

3.
Jones N, Cox R, Thacker J . Isolation and cross-sensitivity of X-ray-sensitive mutants of V79-4 hamster cells. Mutat Res. 1987; 183(3):279-86. DOI: 10.1016/0167-8817(87)90011-3. View

4.
Zimmerman W, Sparks C, Doxsey S . Amorphous no longer: the centrosome comes into focus. Curr Opin Cell Biol. 1999; 11(1):122-8. DOI: 10.1016/s0955-0674(99)80015-5. View

5.
Xu B, Kim St , Kastan M . Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol. 2001; 21(10):3445-50. PMC: 100266. DOI: 10.1128/MCB.21.10.3445-3450.2001. View